Chetan Dev et al. 2024. LONG-TERM CARDIOVASCULAR OUTCOMES AND SAFETY PROFILE OF PCSK9 INHIBITORS IN HIGH-RISK POPULATIONS FOR SECONDARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: A COMPREHENSIVE META-ANALYSIS OF MORTALITY, MAJOR ADVERSE CARDIAC EVENTS, AND METABOLIC IMPACT. Insights – Journal of Health and Rehabilitation. 2, 2 (Health & Allied) (Nov. 2024), 381–388. DOI:https://doi.org/10.71000/ijhr199.